Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 May;17(5):847–855. doi: 10.1128/aac.17.5.847

Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.

P H Vlasses, A M Holbrook, J J Schrogie, J D Rogers, R K Ferguson, W B Abrams
PMCID: PMC283886  PMID: 7396472

Abstract

To characterize the effect of orally administered probenecid on the pharmacokinetics of cefoxitin in healthy male volunteers, we administered to one group of six subjects 2 g of cefoxitin by intravenous (i.v.) bolus either alone, with 1 g of probenecid concomitantly, or when 1 g of probenecid was administered 1 h previously by using a crossover design. Likewise, we administered to a second group of six subjects 2 g of cefoxitin intramuscularly (i.m.) together with 1 and 2 g of probenecid. Probenecid increased the mean terminal half-life and the area under the serum cefoxitin concentration-time curve (AUC0-24) and decreased renal clearance, but did not alter the volume of the central compartment or the total urinary recovery of i.v.-administered cefoxitin; pretreatment with probenecid produced a greater increase in cefoxitin AUC0-24 and a constant decrease in renal clearance compared to concomitant probenecid. The AUC0-24 after i.m.-administered cefoxitin was greater after 2 g than 1 g of probenecid; the AUC0-24 after i.v.-and i.m.-administered cefoxitin was similar after 1 g of probenecid was given concomitantly. Cefoxitin AUC0-24 was increased further when 1 g of probenecid was given before i.v.-administered cefoxitin or when 2 g of probenecid was given with i.m.-administered cefoxitin. The effect of probenecid was related to both timing and dose.

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNELL J. M., KIRBY W. M. M. Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations. J Clin Invest. 1951 Jul;30(7):697–700. doi: 10.1172/JCI102482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berg S. W., Kilpatrick M. E., Harrison W. O., McCutchan J. A. Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1979 Sep 6;301(10):509–511. doi: 10.1056/NEJM197909063011001. [DOI] [PubMed] [Google Scholar]
  3. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979 Jan;17(1):1–37. doi: 10.2165/00003495-197917010-00001. [DOI] [PubMed] [Google Scholar]
  4. Foord R. D. Cefuroxime: human pharmacokinetics.. Antimicrob Agents Chemother. 1976 May;9(5):741–747. doi: 10.1128/aac.9.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gibaldi M., Schwartz M. A. Apparent effect of probenecid on the distribution of penicillins in man. Clin Pharmacol Ther. 1968 May-Jun;9(3):345–349. doi: 10.1002/cpt196893345. [DOI] [PubMed] [Google Scholar]
  6. Goodwin C. S., Raftery E. B., Goldberg A. D., Skeggs H., Till A. E., Martin C. M. Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother. 1974 Sep;6(3):338–346. doi: 10.1128/aac.6.3.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jusko W. J., Gibaldi M. Effects of change in elimination on varous parameters of the two-compartment open model. J Pharm Sci. 1972 Aug;61(8):1270–1273. doi: 10.1002/jps.2600610820. [DOI] [PubMed] [Google Scholar]
  8. Liu C., Hinthorn D. R., Hodges G. R., Harms J. L., Couchonnal G., Dworzack D. L. Penetration of cefoxitin into human cerebrospinal fluid: comparison with cefamandole, ampicillin, and penicillin. Rev Infect Dis. 1979 Jan-Feb;1(1):127–131. doi: 10.1093/clinids/1.1.127. [DOI] [PubMed] [Google Scholar]
  9. Nauta E. H., Mattie H., Goslings W. R. Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin. Antimicrob Agents Chemother. 1974 Sep;6(3):300–303. doi: 10.1128/aac.6.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Reeves D. S., Bint A. J., Holt H. A., Stocks P. J. Cefoxitin sodium: a clinical and pharmacological study. J Antimicrob Chemother. 1978 Jul;4(B):155–160. doi: 10.1093/jac/4.suppl_b.155. [DOI] [PubMed] [Google Scholar]
  11. Rodriguez N., Madsen P. O., Welling P. G. Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother. 1979 Mar;15(3):465–469. doi: 10.1128/aac.15.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schrogie J. J., Davies R. O., Yeh K. C., Rogers D., Holmes G. I., Skeggs H., Martin C. M. Bioavailability and pharmacokinetics of cefoxitin sodium. J Antimicrob Chemother. 1978 Jul;4(B):69–78. doi: 10.1093/jac/4.suppl_b.69. [DOI] [PubMed] [Google Scholar]
  13. Schrogie J. J., Rogers J. D., Yeh K. C., Davies R. O., Holmes G. I., Skeggs H., Martin C. M. Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis. 1979 Jan-Feb;1(1):90–98. doi: 10.1093/clinids/1.1.90. [DOI] [PubMed] [Google Scholar]
  14. Ungethüm W., Pabst J., Dingeldein E., Leopold G. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination. Arzneimittelforschung. 1979;29(2A):443–448. [PubMed] [Google Scholar]
  15. WEINER I. M., WASHINGTON J. A., 2nd, MUDGE G. H. On the mechanism of action of probenecid on renal tubular secretion. Bull Johns Hopkins Hosp. 1960 Jun;106:333–346. [PubMed] [Google Scholar]
  16. Webb D., Thadepalli H., Bach V. Cefoxitin therapy for bacterial endocarditis. Rev Infect Dis. 1979 Jan-Feb;1(1):170–174. doi: 10.1093/clinids/1.1.170. [DOI] [PubMed] [Google Scholar]
  17. Welling P. G., Dean S., Selen A., Kendall M. J., Wise R. Probenecid: an unexplained effect on cephalosporin pharmacology. Br J Clin Pharmacol. 1979 Nov;8(5):491–495. doi: 10.1111/j.1365-2125.1979.tb01032.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yeh K. C. Kinetic parameter estimation by numerical algorithms and multiple linear regression: theoretical. J Pharm Sci. 1977 Dec;66(12):1688–1691. doi: 10.1002/jps.2600661208. [DOI] [PubMed] [Google Scholar]
  19. Yeh K. C., Kwan K. C. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm. 1978 Feb;6(1):79–98. doi: 10.1007/BF01066064. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES